In this context, it is important to again emphasize that PVR is widely expressed, even by most tumor cells, suggesting that CD226 activation may participate in the T cell effector activity more so than CD28, whose activating ligand is limited to immune cells. The gene discussed is CD28; the disease is neoplasm.